Multiorgan failure with fatal outcome after stem cell tourism
Open Access
- 9 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Medical Research
- Vol. 26 (1), 1-5
- https://doi.org/10.1186/s40001-020-00477-4
Abstract
Unproven stem cell treatments may involve serious health, personal, and financial considerations. Due to worldwide spread, illegal stem cell therapies have become a major public health problem. We have already witnessed numerous reports in the mass media of severe and occasionally even fatal outcomes after such therapies. However, there are only few scientifically documented cases in which the causality between stem cell therapy and side effects cannot be refuted. Here we present a case report of a 48-year-old patient with serious side effects, including disseminated skin ulcers, hepatitis, and cardiomyopathy, with eventual fatal outcome following unproven stem cell treatment. The case of the patient presented here draws attention to the worst possible outcome of stem cell tourism. To effectively combat this issue, professionals and patients should be empowered with the right knowledge on possible side effects.Keywords
Other Versions
This publication has 12 references indexed in Scilit:
- Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationThe Lancet Haematology, 2020
- Drug-Induced Liver Injury — Types and PhenotypesThe New England Journal of Medicine, 2019
- Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based InterventionsStem Cells Translational Medicine, 2018
- CalciphylaxisThe New England Journal of Medicine, 2018
- Cutaneous Graft-Versus-Host Disease: Diagnosis and TreatmentAmerican Journal of Clinical Dermatology, 2018
- Severe cutaneous adverse drug reactionsThe Journal of Dermatology, 2016
- Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD)2016
- Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholdersBMC Medical Ethics, 2015
- ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver InjuryThe American Journal of Gastroenterology, 2014
- Calciphylaxis as a Catastrophic Complication in a Patient with POEMS SyndromeCase Reports in Neurology, 2009